Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Periodontitis Response to Anti-TNF Therapy in Ankylosing Spondylitis

Full text
Author(s):
Fabri, Gisele Maria C. [1] ; Pereira, Rosa Maria R. [2] ; Savioli, Cynthia [3] ; Saad, Carla G. S. [2] ; de Moraes, Julio Cesar B. [2] ; Siqueira, Jose Tadeu T. [3] ; Bonfa, Eloisa [2]
Total Authors: 7
Affiliation:
[1] Univ Fed Juiz de Fora, Sch Dent, Juiz De Fora, MG - Brazil
[2] Univ Sao Paulo, Hosp Clin, Div Rheumatol, BR-05403010 Sao Paulo, SP - Brazil
[3] Univ Sao Paulo, Hosp Clin, Dent Div, BR-05403010 Sao Paulo, SP - Brazil
Total Affiliations: 3
Document type: Journal article
Source: JCR-JOURNAL OF CLINICAL RHEUMATOLOGY; v. 21, n. 7, p. 341-345, OCT 2015.
Web of Science Citations: 7
Abstract

Background Recently, it has been demonstrated that patients with ankylosing spondylitis (AS) and rheumatoid arthritis (RA) have a higher risk of periodontitis; however, the effect of anti-TNF therapy in periodontal status of patients with AS and particularly in dental attachment is not known. Objective To evaluate longitudinally the local periodontal effect of TNF-antagonist in AS and compare to patients with RA. Methods Fifteen patients with AS and 15 RA control patients were prospectively evaluated at baseline and after 6 months (6 M) of anti-TNF therapy. Periodontal assessment included: probing pocket depth (PPD), clinical attachment level (CAL), gingival bleeding index, and plaque index. Rheumatologic clinical and laboratory evaluations were the following: Bath AS Disease Activity Index, Bath AS Metrology Index, Bath AS Functional Index, C-reactive protein and erythrocyte sedimentation rate for AS and Disease Activity Score 28 joints, and C-reactive protein and erythrocyte sedimentation rate for patients with RA. Results At baseline, periodontal parameters were alike in AS and RA (P > 0.05). After 6 M of anti-TNF therapy, clinical and laboratory parameters of rheumatic diseases decreased significantly in the patients with AS and RA (P < 0.05). A significant improvement in periodontal attachment measurements were observed in the patients with AS (PPD, 2.18 vs 1.94 mm; P = 0.02; CAL, 2.29 vs.2.02 mm; P = 0.03), but not in RA (PPD, 1.92 vs 2.06 mm; P = 0.06; CAL, 2.14 vs 2.28 mm; P = 0.27). Oral hygiene and gingival inflammation remained unchanged from baseline to 6-M evaluation in AS and RA (P > 0.05). Conclusion Patients with AS under anti-TNF improved periodontal attachment. The mechanism for this effect needs further studies. (AU)